Vaxcyte, Inc. (PCVX) is an innovative biotechnology company headquartered in Foster City, California, focused on the development of next-generation vaccines to combat global infectious diseases. Leveraging its proprietary technology platform, Vaxcyte is advancing a robust pipeline of vaccine candidates designed to elicit strong immune responses and address substantial unmet medical needs. With an unwavering commitment to research and development, the company is well-positioned to make significant contributions to public health and reshape the vaccine landscape, with a particular emphasis on improving patient outcomes and enhancing global health security. Show more
Location: 825 INDUSTRIAL ROAD, SAN CARLOS, CA, UNITED STATES, 94070, San Carlos, CA, 94070, USA | Website: https://vaxcyte.com | Industry: BIOTECHNOLOGY | Sector: HEALTHCARE
Market Cap
7.739B
52 Wk Range
$27.66 - $87.42
Previous Close
$53.91
Open
$55.16
Volume
1,080,778
Day Range
$54.32 - $56.45
Enterprise Value
6.30B
Cash
281.1M
Avg Qtr Burn
-143.3M
Insider Ownership
0.48%
Institutional Own.
-
Qtr Updated
09/30/25
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
| Drug & Indication | Stage & Event | Catalyst Date |
|---|---|---|
VAX-31 Details Infectious disease, Invasive pneumococcal disease, Vaccine | Phase 3 Data readout | |
VAX-31 (PCV Infant) Details Invasive pneumococcal disease | Phase 2 Data readout | |
VAX-24 (PCV Infant) Details Infectious disease, Invasive pneumococcal disease | Phase 2 Update |
